Hypoxia-induced activation of SRC also stimulates downstream activation of FAK, NFκB, HIF1α, and STAT3 in cancer cells, which enhances survival, invasion, metastasis, and chemoresistance [99–102]. This evidence concerns the gene PTK2 and cancer.